Department of Dermatology, Cliniques universitaires Saint-Luc, Brussels, Belgium and IREC (Institut de Recherche Experimentale et Clinique) Pôle Pneumologie, ORL, Dermatologie, Université Catholique de Louvain, Brussels, Belgium.
Contact Dermatitis. 2019 Sep;81(3):167-173. doi: 10.1111/cod.13269. Epub 2019 Apr 12.
The frequency of allergic contact dermatitis has significantly increased in healthcare workers since the transition from latex to synthetic rubber gloves, with 1,3-diphenylguanidine being identified as the most frequently implicated allergen.
To highlight the role of 1,3-diphenylguanidine as the culprit allergen in contact allergies to synthetic rubber gloves, to propose recommendations for patch testing, and to discuss alternatives for sensitized subjects.
Patch test data from healthcare workers who developed hand dermatitis after wearing rubber gloves and who reacted positively to glove samples and rubber additives were collected from September 2010 to December 2017 in a Belgian hospital.
A total of 44 caregivers were included in this study. Patch tests showed that: (a) 84% of the study population reacted positively to carba mix; (b) 86% reacted positively to 1,3-diphenylguanidine; and (c) 13 (30%) reacted positively to thiuram mix. Half of the subjects reacted positively to gloves containing 1,3-diphenylguanidine, whereas none reacted to accelerator-free gloves.
The most commonly identified allergen was 1,3-diphenylguanidine, far ahead of thiurams, which were previously described as the most sensitizing accelerators. The use of 1,3-diphenylguanidine-free gloves is recommended. No subject reacted to gloves without accelerators, thus confirming their efficiency among accelerator-sensitized patients. We recommend that 1,3-diphenylguanidine be added to the European baseline series.
自乳胶向合成橡胶手套转变以来,医护人员的过敏接触性皮炎发病率显著上升,其中 1,3-二苯基胍被认为是最常涉及的变应原。
强调 1,3-二苯基胍作为合成橡胶手套接触过敏的罪魁祸首变应原的作用,提出斑贴试验建议,并讨论致敏患者的替代方案。
从 2010 年 9 月至 2017 年 12 月,在比利时一家医院收集了在佩戴橡胶手套后手部出现皮炎的医护人员的斑贴试验数据,这些医护人员对手套样本和橡胶添加剂呈阳性反应。
本研究共纳入 44 名护理人员。斑贴试验显示:(a)研究人群中有 84%对 carba mix 呈阳性反应;(b)86%对 1,3-二苯基胍呈阳性反应;(c)13 名(30%)对硫脲混合剂呈阳性反应。半数受试者对含 1,3-二苯基胍的手套呈阳性反应,而对不含促进剂的手套则无反应。
最常见的变应原是 1,3-二苯基胍,远远超过以前被描述为最具致敏性的促进剂硫脲。建议使用不含 1,3-二苯基胍的手套。没有受试者对不含促进剂的手套产生反应,从而证实了它们在促进剂致敏患者中的有效性。我们建议将 1,3-二苯基胍添加到欧洲基本系列中。